# Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation

> **NCT00662363** · NA · COMPLETED · sponsor: **Shirley Ryan AbilityLab** · enrollment: 64 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Lubiprostone
- **DRUG:** Senna

## Key facts

- **NCT ID:** NCT00662363
- **Lead sponsor:** Shirley Ryan AbilityLab
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2013-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662363, "Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00662363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*